Strategic Contract Signed for the Supply of an Organic Acid From the AFYREN NEOXY Range in Animal Nutrition
12 Mai 2022 - 8:00AM
Business Wire
- Deal underscores relevance of AFYREN's biobased, circular
and low carbon offering
- AFYREN NEOXY continues to secure long-term sales as it
commercializes a new product from its range
Regulatory News:
AFYREN (Paris:ALAFY), a greentech company that offers
manufacturers natural, low-carbon products created with technology
based on natural micro-organisms, today announced the signature of
a new multi-year structuring contract with a European player in
animal nutrition, for the supply of an organic acid from its AFYREN
NEOXY plant.
Thanks to its proven antimicrobial property, AFYREN's biobased
acid will enable its customer to contribute to animal health with
its nutrition offerings for a wide variety of animal species. The
customer will benefit from a short and reliable supply chain, and a
product with a reduced carbon footprint, produced using sustainable
renewable resources and without palm oil. AFYREN's ingredient also
meet requirements for GMO-free solutions in Europe.
AFYREN's competitive solution provides its customer with a
performance equivalent to a product made from traditional
ingredients, while positioning itself as a sustainable player in
this sector, which is still heavily dependent on fossil resources.
This agreement demonstrates the growing willingness of the
agricultural world, and the animal feed industry in particular, to
use biobased, circular and low-carbon solutions that allow them to
reconcile their activity with the fight against climate
warming.
This multi-year contract also enables AFYREN NEOXY to secure an
additional part of the production of its plant and to capitalize on
its diversified range of acids produced on a single industrial
line.
About AFYREN
Founded in 2012 to meet the growing need of industries to reduce
the use of petroleum derivatives in their production chain, AFYREN
produces biomolecules derived from the reuse of non-food biomass.
These ingredients are widely used in human and animal nutrition,
flavors and fragrances, cosmetics, and fine chemicals. This
production of renewable carbon, which is firmly grounded in the
circular economy, uses fermentation technologies that are the
result of 10 years of research and are patented worldwide. AFYREN
is a winner of the 2030 Global Innovation Contest in the "Plant
proteins and plant chemistry" category and was selected in the
French Tech 120 in 2020 and 2021. In 2018, AFYREN committed to its
industrial project by creating the AFYREN NEOXY joint venture with
Bpifrance’s SPI fund. The AFYREN NEOXY plant under construction in
the Grand Est region will produce AFYREN organic acids in 2022. At
the end of December 2021, AFYREN and AFYREN NEOXY employed more
than 70 people at their sites in Lyon, Clermont-Ferrand and Carling
Saint-Avold. In 2021, AFYREN listed on Euronext Growth® exchange in
Paris, raising a total amount of 70.4 million euros with the
objective of accelerating its industrial development (Afyren's
ISIN: FR0014005AC9, ticker: ALAFY).
For more information: afyren.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220511005685/en/
AFYREN Chief Financial Officer Maxime Cordonnier
investisseurs@afyren.com
Investor Relations NewCap Théo Martin / Mathilde
Bohin Tél : 01 44 71 94 94 afyren@newcap.eu
Media Relations NewCap Nicolas Merigeau Tél : 01
44 71 94 98 afyren@newcap.eu
Bogert-Magnier Communications James Connell Tel : +33 6 2152
1755 jim@bogert-magnier.com
Afyren (EU:ALAFY)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Afyren (EU:ALAFY)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024